Compare MWA & CLDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MWA | CLDX |
|---|---|---|
| Founded | 1857 | N/A |
| Country | United States | United States |
| Employees | 3500 | N/A |
| Industry | Metal Fabrications | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.9B | 3.2B |
| IPO Year | 2006 | 1995 |
| Metric | MWA | CLDX |
|---|---|---|
| Price | $23.84 | $38.83 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 10 |
| Target Price | $30.50 | ★ $46.60 |
| AVG Volume (30 Days) | ★ 810.9K | 694.0K |
| Earning Date | 05-05-2026 | 05-04-2026 |
| Dividend Yield | ★ 1.01% | N/A |
| EPS Growth | ★ 64.86 | N/A |
| EPS | ★ 1.08 | N/A |
| Revenue | ★ $1,429,700,000.00 | $12,743,000.00 |
| Revenue This Year | $4.78 | $111.39 |
| Revenue Next Year | $4.27 | $235.85 |
| P/E Ratio | $22.00 | ★ N/A |
| Revenue Growth | 8.75 | ★ 87.78 |
| 52 Week Low | $22.74 | $22.10 |
| 52 Week High | $31.00 | $45.14 |
| Indicator | MWA | CLDX |
|---|---|---|
| Relative Strength Index (RSI) | 37.94 | 44.63 |
| Support Level | N/A | $28.51 |
| Resistance Level | $25.40 | $40.30 |
| Average True Range (ATR) | 0.48 | 1.37 |
| MACD | -0.10 | -0.36 |
| Stochastic Oscillator | 19.32 | 9.94 |
Mueller Water Products Inc is a U.S.-based company that manufactures and sells products and services used in the transmission, distribution, and measurement of water. The company operates in two segments: Water Flow Solutions and Water Management Solutions. The Water Flow Solutions segment, which derives maximum revenue for the company, includes products like iron gate valves, specialty valves, and service brass products. Water Management Solutions' portfolio includes fire hydrants, repair and installation, natural gas, metering, leak detection, and pressure management and control products and solutions. Geographically, the company derives a majority of its revenue from the United States and the rest from Canada and other international locations.
Celldex Therapeutics Inc is a biopharmaceutical firm focused on mast cell biology and the development of therapeutic antibodies. Its pipeline includes monoclonal and bispecific antibodies aimed at treating severe inflammatory, allergic, autoimmune, and other mast cell-mediated diseases. The company operates in a single operating and reportable segment in the business of development, manufacturing and commercialization of novel therapeutics for human health care.